{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "adds_modification",
    "modifications" : [ {
      "modification_type" : "phosphorylation"
    } ],
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q12778",
      "entity_text" : "p-Foxo1",
      "entity_type" : "protein"
    },
    "is_direct" : false,
    "hypothesis_information" : false,
    "context" : {
      "Cellular_component" : [ "go:GO:0005737" ],
      "Species" : [ "taxonomy:10535" ]
    }
  },
  "verbose_text" : "As illustrated in Fig. XREF_FIG A, B and C, the expression of phosphorylation-Foxo1 (p-Foxo1) was lower in siRab26-DYM, LPS, as well as siRab26-DYM / LPS treated groups than control group and Adv.",
  "reading_complete" : "2020-08-03T13:54:28Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T13:52:23Z",
  "trigger" : "phosphorylation-Foxo1",
  "evidence" : [ "phosphorylation-Foxo1 (p-Foxo1" ],
  "pmc_id" : "5525755",
  "score" : 0
}